Franopolis

    Franchise opportunities compared

    Medi-Weightloss Franchising USA, LLC vs NexGenEsis Healthcare

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Before you compare

    • Medi-Weightloss Franchising USA, LLC figures come from its 2026 FDD and NexGenEsis Healthcare figures from its 2025 FDD, so the years differ.
    • Medi-Weightloss Franchising USA, LLC discloses more than one business format, so the investment range spans formats; the full report breaks them out.
    • Only NexGenEsis Healthcare has reviewed Item 19 figures here.
    DisclosureMedi-Weightloss Franchising USA, LLCNHNexGenEsis Healthcare
    Financial commitment
    Estimated initial investment (Item 7)
    $107,800 – $299,300
    2026 FDD · Item 7
    Not available
    No reviewed Item 7 total
    Standard initial franchise fee (Item 5)
    Not available
    No single standard fee identified
    Not available
    No single standard fee identified
    Royalty (Item 6)
    9% of annual Gross Income up to $300,000; 4½% of annual Gross Income from $300,001 to $600,000; 1% of annual Gross Income over $600,000
    Royalty fee
    2026 FDD · Item 6 · PDF p. 11
    $7.00
    Royalty rate
    2025 FDD · Item 6 · PDF p. 19
    Brand / advertising fund (Item 6)
    $1.00/mo
    Advertising fee — 1% of annual Gross Income, subject to monthly minimum and $6,000 annual maximum per calendar year
    2026 FDD · Item 6 · PDF p. 11
    $1.00
    Brand Fund annual increase cap
    2025 FDD · Item 6 · PDF p. 19
    System scale & health
    Total outlets (Item 20)
    38
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 41
    Not available
    No reviewed outlet counts
    Net outlet change (Item 20)
    −2
    Calculated: 40 at end of 2023 → 38 at end of 2025
    Not available
    Only one year reported
    Outlet exits (Item 20)
    Not available
    No complete exit records for a year
    Not available
    No complete exit records for a year
    Franchising since (Item 1)
    1996
    2026 FDD · Item 1 · PDF p. 8
    Not available
    Not in reviewed records
    Franchisor founded (Item 1)
    1994
    2026 FDD · Item 1 · PDF p. 8
    Not available
    Not in reviewed records
    Performance (Item 19)
    Financial performance (Item 19), by location group
    Not disclosed — no Item 19 financial performance representation
    Franchised (1 locations) — EBITDA and costs and other measures and revenue and profit
    -$64,254.00
    other Adjusted EBITDA · 2025 FDD · Item 19 · PDF p. 63
    Locations counted not stated in the reviewed record
    3 locations
    other Affiliate Reporting Group reporting locations · 2025 FDD · Item 19 · PDF p. 61

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Full Medi-Weightloss Franchising USA, LLC reportFull NexGenEsis Healthcare reportAdd more brands to compare